Import and distribution of pharmaceutical products including orphan drugs, clinical trial supply and early access programs
Swiss Global Pharma Sagl
Lugano-Paradiso (CH)New on Amplifa
About Swiss Global Pharma
Swiss Global Pharma Sagl is a Swiss pharmaceutical service provider founded in 2007, headquartered in Lugano-Paradiso, specialized in the import and distribution of pharmaceutical and medical products worldwide. The company supplies licensed healthcare professionals, companies, hospitals and other healthcare facilities with Swiss and international medicines, including the latest drugs approved by the US FDA and/or Swissmedic. The portfolio covers pharmaceutical wholesaling, sourcing of unlicensed medicines and shortage management, clinical trial supply with comparator sourcing and investigational medicinal products (IMPs), Early Access Programs (EAP) as well as Named Patient Supply (NPS) under Art. 49 of the Swiss Therapeutic Products Act. For small and emerging biotech companies, Swiss Global Pharma offers market entry services including import, customs clearance, documentation and end-to-end distribution without a local legal entity. In addition, Regulatory & Market Access Support and GDP-compliant cold chain logistics with temperature-controlled transport and storage are provided.
- Site
- Lugano-Paradiso, Switzerland
- Processes
- Pharmaceutical wholesaling / distribution of medicines and healthcare products, GDP-compliant cold-chain logistics, temperature-controlled transport and storage, Sourcing and import of unlicensed/unregistered medicines and shortage management, Clinical trial supply: comparator sourcing, IMPs, unlicensed therapies; labelling, release testing,, Early Access Programs (EAP) and Named Patient Supply (NPS) per Art. 49 Swiss TPA, Partnership for small bioscience companies: importing, documentation, customs clearance, end-to-end, Regulatory & market access support (registration, Swissmedic coordination, FDA/EMA reliance,, Pharmaceutical wholesaling
- Materials
- Good Distribution Practices (GDP), EU Clinical Trial Regulation, Swiss Therapeutic Products Act (Art. 49)
- Certificates
- GDP (Good Distribution Practices), GDP-certified according to Swissmedic
- Founded
- 2007
- Industries
- Pharma, Biotech, Clinical trials, Healthcare (hospitals, pharmacies)
- 01
Sourcing via a global supplier network
- 02
Regulatory review and import documentation
- 03
Customs clearance
- 04
Temperature-controlled storage
- 05
GDP-compliant cold chain logistics
- 06
End-to-end distribution to hospitals, clinics, pharmacies and patients
Services
Good Distribution Practices (GDP)
Certification according to Swissmedic for the safe, traceable distribution of pharmaceutical products including cold chain.
EU Clinical Trial Regulation
Compliant importation, labelling and release testing for clinical trial supply according to Swissmedic and the EU CTR.
Swiss Therapeutic Products Act (Art. 49)
Legal basis for Named Patient Supply and Managed Access Programs in Switzerland.
Locations
Lugano-Paradiso
CHHeadquarters with storage and distribution
- Modern storage facilities
- Temperature-controlled transport and storage
- Advanced inventory systems
Products
Inside the production
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Pharmaceutical wholesaling / distribution of medicines and healthcare productsEngineering | – | – | – | – | – |
| GDP-compliant cold-chain logistics, temperature-controlled transport and storageEngineering | – | – | – | – | – |
| Sourcing and import of unlicensed/unregistered medicines and shortage managementEngineering | – | – | – | – | – |
| Clinical trial supply: comparator sourcing, IMPs, unlicensed therapies; labelling, release testing,Engineering | – | – | – | – | – |
| Early Access Programs (EAP) and Named Patient Supply (NPS) per Art. 49 Swiss TPAEngineering | – | – | – | – | – |
| Partnership for small bioscience companies: importing, documentation, customs clearance, end-to-endEngineering | – | – | – | – | – |
| Regulatory & market access support (registration, Swissmedic coordination, FDA/EMA reliance,Engineering | – | – | – | – | – |
Additional services
Quality
Swiss Global Pharma is certified as compliant with the Good Distribution Practices (GDP) requirements of Swissmedic. Modern storage facilities, GDP-compliant cold chain logistics, temperature-controlled transport and advanced inventory systems ensure quality, safety and traceability throughout the entire logistics process.
| Evidence | Lugano-Paradiso |
|---|---|
| GDP-certified according to Swissmedic |
History
- 2007
Founded in Lugano-Paradiso